{"Abstract": [0], "Colorectal": [1], "cancer": [2], "(CRC)": [3], "is": [4], "among": [5], "the": [6, 22, 44, 58, 102, 110], "most": [7], "common": [8], "malignancies": [9], "with": [10, 118], "limited": [11], "treatments": [12], "other": [13], "than": [14], "surgery.": [15], "The": [16], "tumor": [17, 34], "microenvironment": [18], "(TME)": [19], "profiling": [20], "enables": [21], "discovery": [23], "of": [24, 49, 104], "potential": [25, 45, 137], "therapeutic": [26, 126, 138], "targets.": [27], "Here,": [28], "we": [29, 115], "profile": [30], "54,103": [31], "cells": [32], "from": [33, 128], "and": [35, 42, 47, 63, 78, 86, 97, 108, 145], "adjacent": [36], "tissues": [37], "to": [38, 150], "characterize": [39], "cellular": [40], "composition": [41], "elucidate": [43], "origin": [46], "regulation": [48], "tumor-enriched": [50], "cell": [51, 112], "types": [52], "in": [53, 70], "CRC.": [54], "We": [55], "demonstrate": [56], "that": [57], "tumor-specific": [59], "FAP": [60, 120, 142], "+": [61, 65, 143, 147], "fibroblasts": [62, 144], "SPP1": [64, 122, 146], "macrophages": [66, 148], "were": [67], "positively": [68], "correlated": [69], "14": [71], "independent": [72], "CRC": [73], "cohorts": [74], "containing": [75], "2550": [76], "samples": [77], "validate": [79], "their": [80], "close": [81], "localization": [82], "by": [83, 94, 140], "immuno-fluorescent": [84], "staining": [85], "spatial": [87], "transcriptomics.": [88], "This": [89], "interaction": [90, 149], "might": [91], "be": [92], "regulated": [93], "chemerin,": [95], "TGF-\u03b2,": [96], "interleukin-1,": [98], "which": [99], "would": [100], "stimulate": [101], "formation": [103], "immune-excluded": [105], "desmoplasic": [106], "structure": [107], "limit": [109], "T": [111], "infiltration.": [113], "Furthermore,": [114], "find": [116], "patients": [117], "high": [119], "or": [121], "expression": [123], "achieved": [124], "less": [125], "benefit": [127], "an": [129], "anti-PD-L1": [130], "therapy": [131], "cohort.": [132], "Our": [133], "results": [134], "provide": [135], "a": [136], "strategy": [139], "disrupting": [141], "improve": [151], "immunotherapy.": [152]}